BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 14999492)

  • 1. Transcriptional profiles from patients with dystrophinopathies and limb girdle muscular dystrophies as determined by qRT-PCR.
    Arning L; Jagiello P; Schara U; Vorgerd M; Dahmen N; Gencikova A; Mortier W; Epplen JT; Gencik M
    J Neurol; 2004 Jan; 251(1):72-8. PubMed ID: 14999492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy.
    Porter JD; Merriam AP; Leahy P; Gong B; Feuerman J; Cheng G; Khanna S
    Hum Mol Genet; 2004 Feb; 13(3):257-69. PubMed ID: 14681298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in skeletal muscle expression of AQP1 and AQP4 in dystrophinopathy and dysferlinopathy patients.
    Au CG; Butler TL; Egan JR; Cooper ST; Lo HP; Compton AG; North KN; Winlaw DS
    Acta Neuropathol; 2008 Sep; 116(3):235-46. PubMed ID: 18392839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The childhood muscular dystrophies: making order out of chaos.
    Tsao CY; Mendell JR
    Semin Neurol; 1999; 19(1):9-23. PubMed ID: 10711985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysbindin, syncoilin, and beta-synemin mRNA levels in dystrophic muscles.
    Wakayama Y; Matsuzaki Y; Yamashita S; Inoue M; Jimi T; Hara H; Unaki A; Iijima S; Masaki H
    Int J Neurosci; 2010 Feb; 120(2):144-9. PubMed ID: 20199207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Muscular dystrophies detected by immunophenotyping and genotype analysis (mRNA and DNA)].
    Lukás Z; Vojtísková M; Fajkusová L; Bednarík J; Kadanka Z; Hájek J; Hermanová M; Vohánka S; Vytopil M
    Cesk Patol; 2001 Nov; 37(4):137-45. PubMed ID: 11813630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a point mutation and germinal mosaicism in a Duchenne muscular dystrophy family.
    Wilton SD; Chandler DC; Kakulas BA; Laing NG
    Hum Mutat; 1994; 3(2):133-40. PubMed ID: 8199594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
    Wang S; Shen D
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation.
    Gussoni E; Pavlath GK; Lanctot AM; Sharma KR; Miller RG; Steinman L; Blau HM
    Nature; 1992 Apr; 356(6368):435-8. PubMed ID: 1557125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
    Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
    Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic expression patterns of the Drosophila dystrophin-associated glycoprotein complex orthologs.
    Dekkers LC; van der Plas MC; van Loenen PB; den Dunnen JT; van Ommen GJ; Fradkin LG; Noordermeer JN
    Gene Expr Patterns; 2004 Mar; 4(2):153-9. PubMed ID: 15161095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA sequence analysis for structure/function and mutation studies in Becker muscular dystrophy.
    Hamed S; Sutherland-Smith A; Gorospe J; Kendrick-Jones J; Hoffman E
    Clin Genet; 2005 Jul; 68(1):69-79. PubMed ID: 15952989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Muscular dystrophy due to a deficit of gamma-sarcoglycan. A report of three patients with the Delta-521t mutation].
    Eirís-Puñal J; Pintos-Martínez E; Lasa A; Gallano P; Castro-Gago M
    Rev Neurol; 2002 Mar 1-15; 34(5):486-9. PubMed ID: 12040521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dystrophin and dystrophin-associated proteins. Their evaluation at the neuromuscular pathology laboratory].
    Navarro C
    Rev Neurol; 1999 Jan 16-31; 28(2):154-8. PubMed ID: 10101784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration.
    Bakay M; Wang Z; Melcon G; Schiltz L; Xuan J; Zhao P; Sartorelli V; Seo J; Pegoraro E; Angelini C; Shneiderman B; Escolar D; Chen YW; Winokur ST; Pachman LM; Fan C; Mandler R; Nevo Y; Gordon E; Zhu Y; Dong Y; Wang Y; Hoffman EP
    Brain; 2006 Apr; 129(Pt 4):996-1013. PubMed ID: 16478798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of muscle biopsy in analysis of the dystrophin gene in Duchenne muscular dystrophy: experience of a national referral centre.
    Tuffery-Giraud S; Saquet C; Chambert S; Echenne B; Marie Cuisset J; Rivier F; Cossée M; Philippe C; Monnier N; Bieth E; Recan D; Antoinette Voelckel M; Perelman S; Lambert JC; Malcolm S; Claustres M
    Neuromuscul Disord; 2004 Oct; 14(10):650-8. PubMed ID: 15351422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of dystrophin and utrophin staining in childhood muscular dystrophy.
    Sundaram C; Vydehi B; Meena K; Murthy J
    Indian J Pathol Microbiol; 2004 Jul; 47(3):367-9. PubMed ID: 16295426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene.
    Deburgrave N; Daoud F; Llense S; Barbot JC; Récan D; Peccate C; Burghes AH; Béroud C; Garcia L; Kaplan JC; Chelly J; Leturcq F
    Hum Mutat; 2007 Feb; 28(2):183-95. PubMed ID: 17041906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The congenital and limb-girdle muscular dystrophies: sharpening the focus, blurring the boundaries.
    Kirschner J; Bönnemann CG
    Arch Neurol; 2004 Feb; 61(2):189-99. PubMed ID: 14967765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
    Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
    Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.